Clinical Trial: Efficacy and Safety of Low-Dose Esketamine for Postpartum Depression in Parturient with Heart Disease (China)

China, Oct. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Low-Dose Esketamine for Postpartum Depression in Parturient with Heart Disease'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134212

Registration Time: 2026/10/12

Type: Interventional study

Primary Sponsor: Beijing Anzhen Hospital, Capital Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344401

Published by HT Digital Content Services with permission from Health Daily Digest....